Summit Therapeutics’ Ivonescimab Shows Promise (and a Little Peril) in Phase III Trials: Your Definitive Guide to the May 30th 8-K Welcome back to your...
Sirius XM’s Latest 8-K: New Board Members, Happy Shareholders, and the Return of KPMG (Because Who Needs Change?) Welcome back to the ongoing saga of...
Sealed Air Stockholders Say “Yes, Please” to Everything (and the Auditors): Decoding SEE’s Latest 8-K Welcome back to the ongoing saga of Sealed Air Corporation...
D-Wave Cashes In: $80.5 Million Warrant Exercise Fuels Quantum Ambitions After Advantage2 Launch Welcome back to the ongoing saga of D-Wave Quantum Inc. (QBTS), where...
Plus Therapeutics: Cash Infusion & Clinical Wins, But Still on Nasdaq’s Naughty List 🤨 Welcome back to the Plus Therapeutics (PSTV) saga, dear readers. Consider...
PGE’s Power Play: Big Batteries and Bigger Bills? Decoding the Latest 8-K Filing Welcome back to the ongoing saga of Portland General Electric (PGE), where...
PagerDuty’s Q1 2026 10-Q: Green Flags All Around! (But Don’t Get Too Excited Yet) Welcome back to your favorite ongoing saga: Decoding the SEC Filings...
Opendoor Gets a Nasdaq Delisting Notice: From House Flipper to Penny Stock 😬 Welcome back to the ongoing saga of Opendoor Technologies Inc. (OPEN), the...
Energy Vault Holdings, Inc. (NRGV): New Directors and Auditors – Business as Usual? (May 30, 2025) Consider this your official, constantly-updated cheat sheet for all...
ServiceNow’s Logik.io Integration Cruises Along: Shares Unlocked, Lawyers Appeased (May 30, 2025 Update) Welcome back to the ongoing saga of ServiceNow, the company that automates...
FiscalNote’s 2025 Stockholder Meeting: New Faces, Same Accountants, and Absolutely Zero Explosions (So Far) Welcome back to the ongoing saga of FiscalNote Holdings, Inc. (NOTE),...
Neurocrine Biosciences CMO Shuffle: Smooth Succession or Subtle Shift? 🤨 Welcome back to the ongoing saga of Neurocrine Biosciences (NBIX), where the plot thickens faster...
